Longeveron (LGVN) Stock Price
$1.56 0%
to add to portfolio
AI Score

-
Alternative
8 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Longeveron, AI stock picks, stock alerts and much more.
LGVN AI Stock Analysis
AI stock analysis for LGVN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Longeveron (LGVN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Longeveron (LGVN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Longeveron (LGVN), currently trading at $1.56, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About LGVN

-
Longeveron Inc.
-
Symbol
LGVN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
23.1M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
LGVN Alternative Data
Web Traffic
Longeveron receives an estimated 2350 monthly visitors to longeveron.com.
-
Web Traffic
2350
-
Change from Previous Month
5.6%
-
3 Month Change
14.1%
-
YoY Change
14.1%
News Mentions
Longeveron was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Longeveron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Longeveron has 340 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.
-
Twitter Followers
340
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
3%
Instagram Followers
Longeveron has 554 Instagram Followers on its main Instagram, down by -0.7% over the last month.
-
Instagram Followers
554
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
27.9%
LinkedIn Followers
3,504 are following Longeveron on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
3504
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
5.9%
Job Postings
Longeveron currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Longeveron has 30 employees.
-
LinkedIn Employees
30
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
15.4%
LGVN Financials
LGVN Key Metrics
-
Total Revenue
$773K
-
Net Income
-$4.4M
-
Earnings per Share
-$0.34
-
Free cash flow
-$2.5M
-
EBITDA
-$4.4M
-
EBITDA Ratio
-5.71022
-
Total Assets
$29.9M
LGVN 2-year Revenue & Income
LGVN 2-year Free Cash Flow
LGVN Technicals
LGVN SMA
LGVN RSI
FAQ
What's the current price of Longeveron (LGVN) Stock?
The price of an Longeveron (LGVN) share is $1.56.
What's the market cap of Longeveron?
The current market cap of Longeveron is 23.1M.
Should I buy or sell LGVN?
Longeveron shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Longeveron is better viewed as a hold or accumulate position while waiting for further developments.
Is Longeveron a good investment?
The current analysis of Longeveron's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Longeveron's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Longeveron (LGVN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Longeveron stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Longeveron (LGVN) that investors often compare it to?
Longeveron (LGVN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Longeveron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Longeveron's stock price to be around $1.56 in 2026. Starting from the current price of $1.56, this represents a 0.1% change in price, indicating a neutral outlook for the stock.
How to buy Longeveron (LGVN) Stock?
Longeveron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Longeveron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.